Amplification of the HER2/neu gene and increased expression of the HER2/neu protein were reported in 20% of breast carcinoma patients which were accompanied by an aggressive phenotype, metastases with a poor prognosis [5]. This evidence concerns the gene ERBB2 and breast carcinoma.